NEWS2023-10-16T18:47:55+00:00

Latest News from the NCDIR

911, 2017

The NCDIR is in the News!

November 9, 2017|

John LaCava, of the Rout Lab, was recently profiled and featured on researchfeatures.com talking about raising åantibodies against protein complexes! Read the full article on researchfeatures.com!

Dr. John LaCava of Rockefeller

208, 2017

Summer Teaching in Barcelona by our NCDIR members!

August 2, 2017|

Dr. John LaCava and Dr. Natalia Ketaren from the Rout Lab were invited to teach a research program at The School of Molecular and Theoretical Biology held in Barcelona, Spain. The Zimin Foundation funded school is under the helm of HHMI investigator Dr. Fyodor Kondrashov, and teaches late high-school students and early undergraduates various scientific research projects, each mentored by world –renowned scientists, over a course of 2 weeks.

Students get hands-on experience of what it is like to conceive, develop and carry-out hypothesis driven scientific research, performing either computational driven work or benchwork, culminating in a conference showcasing the novel findings of each labs research project. This is the 2nd year in a row that Dr. LaCava with the help of Dr. Ketaren carried out a research course for the school.

The School of molecular and theoretical biology, Class of 2017, Barcelona, Spain.

To read more about the School of Molecular and Theoretical Biology and the projects carried out by Dr. LaCava and Dr. Ketaren at the school see below!

http://molbioschool.com/en/
http://molbioschool.com/en/archive/school-2017.html

2004, 2017

Prof. John Aitchison – New Director and President of the CID

April 20, 2017|

Congratulations to Prof. John Aitchison, who has been appointed the president and director of the Center for Infectious Disease Research (CID Research) in Seattle, WA! With over 300 staff and over 100 partners, the CID is the largest non-profit organization in the US whose research is dedicated to the study of infectious diseases. Infectious diseases such as malaria affect over 200 million people globally1. Some of the world’s most vulnerable populations are severely affected, with little to no access to treatment. The CID is focused on developing vaccines and treatment options against such volatile diseases, in the hope of reducing their impact on human health in the near future.

We at the NCDIR congratulate Prof Aitchison on his new appointment and wish him all the best at the helm of the CID!

Read more about John’s new appointment and the CID here!

Go to Top